A Comprehensive Board Review in Hematology and Medical Oncology - 2026

1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology.
2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
3. Demonstrate proficiency of knowledge in hematology and medical oncology.
4. Incorporate recent advances in management of hematologic and oncologic patients.

A Virtual Live Streaming Course

The Comprehensive Board Review in Hematology and Medical Oncology will be virtual. This program will be presented only as a live streaming course.

PLANNING COMMITTEE
MD Anderson Cancer Center
Sharon Giordano, MD, MPH, Co-Director
Tapan Kadia, MD, Co-Director
Shreyaskumar Patel, MD
Alessandra Ferrajoli, MD
Nishin Bhadka, MD
Felisha Estelle

Baylor College of Medicine
Martha Mims, MD, PhD, Co-Director

PRESENTATIONS
Course syllabus will not be printed. Presentations (slides) will be available online via the course platform and Canvas. The PowerPoint presentations will be posted online as PDFs prior to the conference. You will receive an invitation email with directives to log in Canvas.

• The Full Conference and Oncology Session will begin at 7:30 a.m. (CDT) on Monday, September 14.  The Oncology Session will adjourn at 12:00 p.m. on Friday, September 18 .

• The Hematology Session will begin at 7:30 a.m. (CDT) on Thursday, September 17 and adjourn on Saturday, September 19.

Advanced registration is encouraged.  Please see the registration fees below.

*NOTE: The conference registration fee includes the tuition, access to course virtual platform with PDFs of the slides and Canvas - online web-based system with recorded videos.

The early bird registration deadline is Monday, August 24, 2026.

Telephone registrations are not accepted.

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)

• Check (payable through U.S. banks only)

• Mail to: Continuing Professional Education – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

REFUND/CANCELLATION POLICY
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Monday, August 24, 2026.  No refunds will be granted after that date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.  For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866.

Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of Continuing Professional Education is limited to the registration fee.  Continuing Professional Education will refund the full registration fee.

Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity by emailing Continuing Professional Education at [email protected]. All responses will be forwarded to the Program Directors for consideration.

EVALUATION
An online course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

SPECIAL ASSISTANCE
Contact Felisha Estelle in Continuing Professional Education at 713-745-0083 or 1-866-531-MOBR (6627) if you have any ADA accommodation needs.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 51.25 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 Maintenance of Certification

American Board of Internal Medicine (ABIM)
Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn up to 51.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CE credits claimed for the activity. It is the CE activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf. 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Tapan M. Kadia, MD
Professor
The University of Texas MD Anderson Cancer Center

Activity Co-Director

Grant or research support-Bristol-Myers Squibb Company|Honoraria-DAVA Oncology|Speakers Bureau-CURE|Honoraria-DrenBio|Grant or research support-Dren Bio|Grant or research support-Celgene Corporation (Relationship has ended)|Grant or research support-BMS|Honoraria-Biologix (Relationship has ended)|Grant or research support-Janssen Biotech, Inc. (Relationship has ended)|Grant or research support-Incyte Corporation|Grant or research support-Astex|Grant or research support-Abcuro|Grant or research support-Pfizer Inc.|Honoraria-Hikma Pharmaceuticals|Consulting Fee-Genzyme Corporation (Relationship has ended)|Grant or research support-Glycomimetics|Consulting Fee-Sellas|Grant or research support-Sellas|Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc. (Relationship has ended)|Grant or research support-Genentech, Inc.|Grant or research support-Ascentage|Grant or research support-Cellenkos (Relationship has ended)|Grant or research support-AstraZeneca US (Relationship has ended)|Grant or research support-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Paid consultant-AbbVie Inc.|Paid consultant-Genentech, Inc.|Grant or research support-Genfleet|Grant or research support-Sellas, Inc|Grant or research support-Delta Fly Pharma (Relationship has ended)|Grant or research support-Jazz Pharmaceuticals|Paid consultant-Jazz Pharmaceuticals|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Agios Pharmaceuticals Inc.|Consulting Fee-PinotBio (Relationship has ended)|Consulting Fee-Sanofi US (Relationship has ended)|Paid consultant-Pfizer Inc.|Grant or research support-Regeneron Pharmaceuticals, Inc.|Consulting Fee-Servier Pharmaceuticals|Consulting Fee-Syndax|Consulting Fee-Kura

Martha Mims, MD, PhD
Professor and Section Chief, Hematology/Oncology
Baylor College of Medicine

Activity Co-Director

Stocks or stock options, excluding diversified mutual funds-Amgen Inc.|Stocks or stock options, excluding diversified mutual funds-Biogen Inc.|Grant or research support-Janssen Biotech, Inc. (Relationship has ended)|Grant or research support-Celgene Corporation (Relationship has ended)|Grant or research support-Incyte Corporation (Relationship has ended)|Grant or research support-inovio

Sharon H. Giordano, MD, FASCO
Professor
The University of Texas MD Anderson Cancer Center

Activity Co-Director, Content Reviewer

Nothing to disclose

Teresa Moon, MD
MD Anderson Cancer Center

CE Reviewer

Nothing to disclose

Felisha Estelle, BBA
CE Activity Planner
The University of Texas MD Anderson Cancer Center

CPE Planner

Nothing to disclose

Nishin Bhadkamkar, MD
Associate Professor
The University of Texas MD Anderson Cancer Center

Planning Committee Member

Nothing to disclose

Alessandra Ferrajoli, MD
Professor of Medicine
The University of Texas MD Anderson Cancer Center

Planning Committee Member

Membership on Advisory Committees or Review Panels, Board Membership, etc.-AbbVie Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US (Relationship has ended)

Shreyaskumar Patel, MD
Professor - Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Planning Committee Member

Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Deciphera|Consulting Fee-Kura Oncology|Consulting Fee-Parabilis